{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:50:52Z","timestamp":1791625852993,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,10]],"date-time":"2027-10-10T00:00:00Z","timestamp":1823126400000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19kk0305009"],"award-info":[{"award-number":["JP19kk0305009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23kk0305025"],"award-info":[{"award-number":["JP23kk0305025"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama121019"],"award-info":[{"award-number":["JP25ama121019"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.dmd.2026.100408","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:14:24Z","timestamp":1789661664000},"page":"100408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional characterization of rare DPYD variants identified in 8,380 Japanese individuals: implications for 5-fluorouracil metabolism"],"prefix":"10.1016","volume":"54","author":[{"given":"Kento","family":"Terauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-5120","authenticated-orcid":false,"given":"Eiji","family":"Hishinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5376-3670","authenticated-orcid":false,"given":"Sakae","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8256-0735","authenticated-orcid":false,"given":"Shu","family":"Tadaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-0298","authenticated-orcid":false,"given":"Masamitsu","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariyasu","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7296-8350","authenticated-orcid":false,"given":"Yuu","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3767-7686","authenticated-orcid":false,"given":"Masahiro","family":"Hiratsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dmd.2026.100408_bib1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ijc.29025","article-title":"Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity","volume":"136","author":"Froehlich","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.dmd.2026.100408_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4251\/wjgo.v8.i5.439","article-title":"Current adjuvant treatment modalities for gastric cancer: from history to the future","volume":"8","author":"Kilic","year":"2016","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100408_bib3","first-page":"238","article-title":"A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer","volume":"10","author":"Lucas","year":"2011","journal-title":"Clin Colorectal Cancer"},{"issue":"29","key":"10.1016\/j.dmd.2026.100408_bib4","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.2174\/092986711797287584","article-title":"Development of 5-Fluorouracil derivatives as anticancer agents","volume":"18","author":"Pan","year":"2011","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.dmd.2026.100408_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jjco\/hyi214","article-title":"Intermediate dose 5-fluorouracil-induced encephalopathy","volume":"36","author":"Kim","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100408_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxlet.2014.03.018","article-title":"A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives","volume":"227","author":"Lamberti","year":"2014","journal-title":"Toxicol Lett"},{"issue":"11","key":"10.1016\/j.dmd.2026.100408_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/jamaoncol.2017.1269","article-title":"Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial","volume":"3","author":"Yap","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.dmd.2026.100408_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2016.08.001","article-title":"The role of pharmacogenetics in capecitabine efficacy and toxicity","volume":"50","author":"Lam","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.dmd.2026.100408_bib10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1186\/s12885-016-2826-8","article-title":"Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma","volume":"16","author":"Kunicka","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.dmd.2026.100408_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cca.2012.08.015","article-title":"A new DPYD genotyping assay for improving the safety of 5-fluorouracil therapy","volume":"414","author":"Sistonen","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100408_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbapap.2004.06.009","article-title":"Dihydropyrimidine dehydrogenase: a flavoprotein with four iron-sulfur clusters","volume":"1701","author":"Schnackerz","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"26","key":"10.1016\/j.dmd.2026.100408_bib13","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1021\/acs.biochem.0c00223","article-title":"Transient-state analysis of porcine dihydropyrimidine dehydrogenase reveals reductive activation by NADPH","volume":"59","author":"Beaupre","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.dmd.2026.100408_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.109066","article-title":"Mammalian dihydropyrimidine dehydrogenase","volume":"714","author":"Forouzesh","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.dmd.2026.100408_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109517","article-title":"Mammalian dihydropyrimidine dehydrogenase: added mechanistic details from transient-state analysis of charge transfer complexes","volume":"736","author":"Smith","year":"2023","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.dmd.2026.100408_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0021-9258(19)70122-7","article-title":"Purification and properties of dihydrothymine dehydrogenase from rat liver","volume":"256","author":"Shiotani","year":"1981","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.dmd.2026.100408_bib17","first-page":"1239","article-title":"Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil","volume":"55","author":"Spector","year":"1995","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.dmd.2026.100408_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163105","article-title":"Degradation rate of 5-fluorouracil in metastatic colorectal cancer: a new predictive outcome biomarker?","volume":"11","author":"Botticelli","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.dmd.2026.100408_bib19","first-page":"4363","article-title":"Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity","volume":"9","author":"van Kuilenburg","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.dmd.2026.100408_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2217\/pgs.09.28","article-title":"Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment","volume":"10","author":"Amstutz","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"16","key":"10.1016\/j.dmd.2026.100408_bib21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S1470-2045(15)00286-7","article-title":"Clinical relevance of DPYD variants c.1679T>G, c.1236G>A\/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Meulendijks","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.dmd.2026.100408_bib22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2217\/pgs.11.72","article-title":"Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity","volume":"12","author":"Amstutz","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"7","key":"10.1016\/j.dmd.2026.100408_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejca.2003.12.004","article-title":"Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil","volume":"40","author":"van Kuilenburg","year":"2004","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.dmd.2026.100408_bib24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00280-016-3137-0","article-title":"Patients homozygous for DPYD c.1129-5923C>G\/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines","volume":"78","author":"Meulendijks","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100408_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.2015.63.1325","article-title":"Upfront genotyping of DPYD\u22172A to individualize fluoropyrimidine therapy: a safety and cost analysis","volume":"34","author":"Deenen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100408_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt.911","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update","volume":"103","author":"Amstutz","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.dmd.2026.100408_bib27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2217\/pgs.15.70","article-title":"Translating DPYD genotype into DPD phenotype: using the DPYD gene activity score","volume":"16","author":"Henricks","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.dmd.2026.100408_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.930470","article-title":"Importance of rare DPYD genetic polymorphisms for 5-fluorouracil therapy in the Japanese population","volume":"13","author":"Hishinuma","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2026.100408_bib29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1124\/dmd.118.081737","article-title":"Functional characterization of 21 allelic variants of dihydropyrimidine dehydrogenase identified in 1070 Japanese individuals","volume":"46","author":"Hishinuma","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2026.100408_bib30","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3390\/jcm9082342","article-title":"In vitro assessment of fluoropyrimidine-metabolizing enzymes: dihydropyrimidine dehydrogenase, dihydropyrimidinase, and \u03b2-ureidopropionase","volume":"9","author":"Hishinuma","year":"2020","journal-title":"J Clin Med"},{"issue":"D1","key":"10.1016\/j.dmd.2026.100408_bib31","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkad978","article-title":"jMorp: Japanese Multi-Omics Reference Panel update report 2023","volume":"52","author":"Tadaka","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.dmd.2026.100408_bib32","doi-asserted-by":"crossref","first-page":"D536","DOI":"10.1093\/nar\/gkaa1034","article-title":"jMorp updates in 2020: large enhancement of multi-omics data resources on the general Japanese population","volume":"49","author":"Tadaka","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.dmd.2026.100408_bib33","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1158\/0008-5472.CAN-12-3858","article-title":"Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity","volume":"73","author":"Offer","year":"2013","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.dmd.2026.100408_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/cpt.1020","article-title":"Gene-specific variant classifier (DPYD-Varifier) to identify deleterious alleles of dihydropyrimidine dehydrogenase","volume":"104","author":"Shrestha","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100408_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bcp.2017.06.121","article-title":"Functional characterization of 21 allelic variants of dihydropyrimidinase","volume":"143","author":"Hishinuma","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100408_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.122.001045","article-title":"Functional characterization of 12 dihydropyrimidinase allelic variants in japanese individuals for the prediction of 5-fluorouracil treatment-related toxicity","volume":"51","author":"Hishinuma","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2026.100408_bib37","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1158\/0008-5472.CAN-13-2482","article-title":"Comparative functional analysis of DPYD variants of potential clinical relevance to dihydropyrimidine dehydrogenase activity","volume":"74","author":"Offer","year":"2014","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.dmd.2026.100408_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00008571-200203000-00007","article-title":"A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms","volume":"12","author":"Mattison","year":"2002","journal-title":"Pharmacogenetics"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562600677X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562600677X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:31:16Z","timestamp":1791624676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562600677X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S009095562600677X"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100408","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of rare DPYD variants identified in 8,380 Japanese individuals: implications for 5-fluorouracil metabolism","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100408"}}